Hemodialysis Blood Tubing Set
National Medical Care, Medical Products Div.
FDA Clearance Information
The hemodialysis blood tubing set was cleared by the FDA through the 510(k) pathway on September 21, 1992. It is manufactured by National Medical Care, Medical Products Division and is classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Used as blood tubing for extracorporeal blood circulation during hemodialysis.
- Used to connect the patient's vascular access to the hemodialysis machine and dialyzer.
Clinical Applications
- Hemodialysis for patients with chronic kidney disease and kidney failure.
- Hemodialysis for patients with acute kidney injury when extracorporeal blood circulation is required.
- Connection of an arteriovenous fistula, arteriovenous graft, or dialysis catheter to the hemodialysis circuit.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Tubing sets must be compatible with the dialysis machine, dialyzer, vascular access, anticoagulation system, and prescribed treatment flow rates.
- The set is sterile and intended for single use; it should be inspected for damage, leaks, particulate matter, or expired packaging before use.
- Correct connection of the arterial and venous limbs is essential to reduce the risk of blood loss, air entry, clotting, or inadequate dialysis.
- This external tubing is not an implanted device and is not independently evaluated as an MRI device; MRI safety depends on the complete dialysis setup and whether the machine and circuit can be removed from the scanner environment.
- Potential complications include bleeding, air embolism, blood loss, clotting, infection, hemolysis, and inaccurate monitoring if the tubing is incorrectly connected or handled.
Frequently Asked Questions
What are the clinical indications for hemodialysis blood tubing set?
The device is indicated for use in hemodialysis to facilitate blood flow between the patient and the dialysis machine, primarily for patients with renal failure.
What outcomes have been reported in clinical studies?
Studies report effective facilitation of dialysis, with noted immune responses and iron loss as key outcomes.
What complications have been reported?
Safety data indicate hypersensitivity reactions and hemolysis as potential complications during use.